DS
Dharmendra Singh Thakur
About Dharmendra Singh Thakur
Data last updated:
Dharmendra Singh Thakur is an Additional Director at Urmed Pharmaceutical Private Limited (since 2023) and Partner at Maxus Pharmaceuticals Llp (since 2021). The companies operate in Pharma and Home Appliances. The largest current company by reported revenue is Urmed Pharmaceutical Private Limited at ₹20.2 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 05 Apr 2023 | 2020 | ₹20.2 Lakh (FY 2023) | Active | |
| Partner | 21 Oct 2021 | 2021 | Active |
Board colleagues of Dharmendra Singh Thakur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Vikas Gupta | 09014870 | Urmed Pharmaceutical Private Limited | Director |
| Vikas Patel | 09014872 | Urmed Pharmaceutical Private Limited | Director |
| Ankush Baheti | 09366736 | Maxus Pharmaceuticals Llp | Designated Partner |
| Nirmesh Sharma | 09366737 | Maxus Pharmaceuticals Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dharmendra Singh Thakur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dharmendra Singh Thakur
Dharmendra Singh Thakur currently holds 2 directorships: Urmed Pharmaceutical Private Limited (Additional Director, since 05 Apr 2023, revenue ₹20.2 Lakh (FY 2023)); Maxus Pharmaceuticals Llp (Partner, since 21 Oct 2021).
Dharmendra Singh Thakur was first appointed on 21 Oct 2021 as Partner at Maxus Pharmaceuticals Llp. The most recent appointment on record is 05 Apr 2023 at Urmed Pharmaceutical Private Limited.
The current boards of Dharmendra Singh Thakur's companies include Vikas Gupta (Urmed Pharmaceutical Private Limited), Vikas Patel (Urmed Pharmaceutical Private Limited), Ankush Baheti (Maxus Pharmaceuticals Llp), Nirmesh Sharma (Maxus Pharmaceuticals Llp).